NCO 700

Known as: NCO-700 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2000
01219822000

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Activation of trypsinogen is thought to trigger the autodigestive process in acute pancreatitis. The lysosomal enzyme cathepsin B… (More)
Is this relevant?
1994
1994
To explore the role of calcium-dependent protease in the stunned myocardium, open-chest dogs underwent 15 min of left anterior… (More)
Is this relevant?
1991
1991
The effect of NCO-700 (1), a protease inhibitor, on subcellular distribution of lysosomal enzymes was studied in the ischemic… (More)
Is this relevant?
1989
1989
To clarify the physiological role of calcium-activated neutral protease (CANP) in human platelets, we loaded the platelets with a… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1988
1988
The specific thiol protease inhibitor, NCO-700, which is related to L-trans-epoxysuccinylpeptides, inhibited oxidant production… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
1986
1986
The synthetic protease inhibitor bis[ethyl(2R,3R)-3-[(S)-methyl-1-[4-(2,3,4-tri-methoxyphenyl-methyl) piperazine-1-ylcarbonyl… (More)
Is this relevant?
1986
1986
The administration (i.v., 20, 40 and 60 mg/kg) of the thiol protease inhibitor bis[ethyl(2R, 3R)-3-[(S)-methyl-1-[4-(2,3,4… (More)
Is this relevant?
1985
1985
During myocardial ischemia in dogs effects of NCO-700, a protease inhibitor on myocardial pH, were investigated. Ischemia was… (More)
Is this relevant?
1985
1985
NCO-700 is a newly synthesized inhibitor of both cathepsin B and calcium-activated neutral protease. We examined whether NCO-700… (More)
Is this relevant?
1982
1982
Calcium-activated neutral protease (CANP) might be involved in the irreversible degradation of myocardial proteins in the… (More)
Is this relevant?